基线功能性膀胱容量对短期神经调节结局的影响
本研究基于前瞻性神经调节数据库,评估216例患者基线功能性膀胱容量(FBC)与分期神经调节术后3个月临床结局的关系。基线FBC在植入与非植入患者间相似(P = .17);植入患者电极放置后FBC中位增加19 mL,而非植入患者下降2.7 mL(P = .0014)。电极放置后FBC变化百分比与脉冲发生器植入强相关(P = .021;C统计量0.68),但基线FBC或FBC变化与症状改善无关;基线FBC < 150 mL组FBC显著改善,两组症状均显著改善。
要点
- 植入患者电极放置后FBC中位增加19 mL,非植入患者下降2.7 mL(P = .0014)。
- 电极放置后FBC变化百分比与IPG植入相关(P = .021;C统计量0.68)。
- 基线FBC或FBC变化与症状改善无关;基线FBC < 150 mL组FBC显著改善,两组症状均显著改善。
核心结论
- FBC改善与IPG植入相关,但与其他症状指标无关。
- 基线FBC低(< 150 mL)的患者也获得了显著的症状改善。
研究设计与样本
- 前瞻性神经调节数据库中的成人患者,共216例(平均年龄59岁;84%女性),随访3个月。
主要发现
- 216例中71%有尿急和尿频伴或不伴急迫性尿失禁,82%行骶神经电极放置,92%行IPG植入。
- 基线FBC在植入与非植入患者间相似(P = .17)。
- 植入患者电极放置后FBC中位增加19 mL,非植入患者下降2.7 mL(P = .0014)。
- 电极放置后FBC变化百分比与IPG植入强相关(P = .021;C统计量0.68),但基线FBC(mL)与IPG植入无关。
- 基线FBC(mL)或电极放置后FBC变化百分比与症状改善无关;按基线FBC < 150 mL和≥ 150 mL分组,仅< 150 mL组FBC显著改善,但两组症状均显著改善。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the impact of functional bladder capacity (FBC) on clinical outcomes after a staged neuromodulation procedure. MATERIALS AND METHODS: Adults in our prospective neuromodulation database were evaluated. Data were collected from medical records, voiding diaries (FBC defined as average volume per void), Interstitial Cystitis Symptom Index-Problem Index, Overactive Bladder Questionnaire, and Global Response Assessment over 3 months. Descriptive statistics, Pearson's chi-square tests, Wilcoxon rank sum tests, logistic regression, repeated measures analyses, and Spearman correlation coefficients were performed. RESULTS: Of the 216 patients (mean age 59 years; 84% female), most had urinary urgency and frequency with or without urge incontinence (71%), a sacral lead placement (82%), and implantable pulse generator (IPG) implantation (92%). Baseline FBC was similar between implanted and not implanted patients (P = .17); however implanted patients had a median 19 mL increase in FBC after lead placement compared to a 2.7 mL decrease in explanted patients (P = .0014). There was a strong association between percent change in FBC after lead placement and IPG implantation (P = .021; C-statistic 0.68), but baseline FBC (mL) was not associated. Baseline FBC (mL), or percent change in FBC after lead placement, was not related to symptom improvement. When grouped by baseline FBC < 150 mL and FBC ≥ 150 mL, FBC only improved significantly in the <150 group but both demonstrated significant improvements in symptoms. CONCLUSION: FBC improvements were associated with IPG implantation but not other symptom measures. Patients with low FBC (baseline FBC < 150) also achieved significant improvements in symptoms.
引用
- Killinger KA, Gupta P, Gilleran JP, et al. The Impact of Baseline Functional Bladder Capacity on Short-term Neuromodulation Outcomes. Urology. 2017. PMID: 28093307. doi:10.1016/j.urology.2017.01.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。